CME Group plans E-mini equity factor futures launch on Sept. 21
- CME Group plans to launch E-mini Equity Factor futures on September 21
- The launch is pending final regulatory review
- This expands CME Group's equity product suite
- No specific contract details were disclosed yet

*this image is generated using AI for illustrative purposes only.
CME Group plans to launch E-mini Equity Factor futures on September 21, pending regulatory review. The move expands the world’s leading derivatives marketplace’s equity product suite.
The Chicago-based exchange stated the new contracts will be added to its existing offerings, subject to final regulatory approval. No specific details regarding contract specifications or initial trading volumes were disclosed in the announcement.
Product Expansion
The introduction of these factor-based futures represents a strategic addition to CME Group’s equity derivatives lineup. By launching E-mini versions, the exchange likely aims to provide accessible exposure to specific equity factors for a broader range of investors.
Regulatory clearance remains the final hurdle before the September 21 start date. Until then, market participants await further technical specifications and trading rules.
Which specific equity factors (e.g., value, momentum, quality) will these new E-mini futures target, and how might this influence factor rotation strategies?
How will the introduction of CME's factor futures impact trading volumes and liquidity in existing ETFs or single-stock options that currently serve as proxies for these factors?
What potential regulatory concerns regarding market manipulation or concentration risk could delay the final approval beyond the September 21 target date?

































